Rapport Therapeutics, Inc. Common Stock (RAPP)

18.83

(-1.26%)

Total Debt Summary of Rapport Therapeutics, Inc. Common Stock

  • Rapport Therapeutics, Inc. Common Stock's latest annual total debt in 2023 was 2.14 Million USD , down 0.0% from previous year.
  • Rapport Therapeutics, Inc. Common Stock's latest quarterly total debt in 2024 Q2 was 1.82 Million USD , down -8.27% from previous quarter.
  • Rapport Therapeutics, Inc. Common Stock reported annual total debt of - USD in 2022, down 0.0% from previous year.
  • Rapport Therapeutics, Inc. Common Stock reported quarterly total debt of 1.98 Million USD for 2024 Q1, down -7.55% from previous quarter.
  • Rapport Therapeutics, Inc. Common Stock reported quarterly total debt of 2.14 Million USD for 2023 FY, down 0.0% from previous quarter.

Annual Total Debt Chart of Rapport Therapeutics, Inc. Common Stock (2023 - 2022)

Historical Annual Total Debt of Rapport Therapeutics, Inc. Common Stock (2023 - 2022)

Year Total Debt Total Debt Growth
2023 2.14 Million USD 0.0%
2022 - USD 0.0%

Peer Total Debt Comparison of Rapport Therapeutics, Inc. Common Stock

Name Total Debt Total Debt Difference